Increasing Recovery of Phosphorylated Peptides Using ACQUITY PREMIER Technology Featuring MaxPeak High Performance Surfaces
Applications
| 2021 | Waters
LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Proteomics
Maximizing Phosphopeptide Recovery in LC-MS Studies with MaxPeak High Performance Surfaces Technology
Applications
| 2021 | Waters
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Manufacturer
Waters
Industries
Proteomics
Demonstrating the Waters RADIAN ASAP Direct Ionization Detector as a Rapid Screening Tool for Discovery Reaction Monitoring
Applications
| 2021 | Waters
LC/MS, DART, LC/SQ
Instrumentation
LC/MS, DART, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Evaluating BioAccord LC-MS System Performance for Deployment of a Compact, SmartMS-Enabled Biopharma Solution in Late Stage Development and QC Environment – Intact Mass Analysis
Applications
| 2020 | Waters
LC/TOF, LC/HRMS, LC/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS
Manufacturer
Waters
Industries
Clinical Research
Targeted UPLC-MS/MS Analysis of Oxylipins
Applications
| 2020 | Waters
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Waters
Industries
Clinical Research
Comprehending COVID-19: Maximizing LC-MS Detection Dynamic Range for Multiple Reaction Monitoring Based SARS-CoV-2 Analysis
Applications
| 2020 | Waters
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Waters
Industries
Clinical Research
Determination and quantitation of drugs of abuse and designer opioids in serum
Applications
| 2019 | Bruker
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Bruker
Industries
Forensics
DETERMINATION OF LEGACY AND EMERGING PERFLUOROALKYL SUBSTANCES IN GROUND AND SURFACE WATERS USING LC-MS/MS FOLLOWING ENRICHMENT BY SPE
Posters
| 2019 | Waters (NACRW)
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Waters
Industries
Environmental
NATIVE MASS SPECTROMETRY DISTINGUISHES HOMO VS HETERO NON-COVALENT DIMERIC AGGREGATES OF MONOCLONAL ANTIBODIES